As of Jul 25, 2024, the Incyte stock's PE ratio is 20.59. This results from the current EPS of $3.33 and stock price of $68.57. The P/E ratio has decreased by 25% from the past four quarters average of 27.3.
The PE ratio of Incyte has averaged 237.56 over the last ten years. The current PE ratio of 20.59 is 91% below the historical average. In the past ten years, INCY's PE ratio was at its highest in the Dec 2015 quarter at 2,711.25, when the stock price was $108.45 and the EPS was $0.04. The lowest value was in the Sep 2022 quarter, when it reached 16.83 with a price of $66.64 and an EPS of $3.96.
Maximum annual increase: 207.56% in 2022
Maximum annual decrease: -93.28% in 2016
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 23.52 | -55.2% |
| 2022 | 52.5 | 207.56% |
| 2021 | 17.07 | N/A |
| 2020 | N/A | N/A |
| 2019 | 41.98 | -65.67% |
| 2018 | 122.29 | N/A |
| 2017 | N/A | N/A |
| 2016 | 182.31 | -93.28% |
| 2015 | 2,711.25 | N/A |
| 2014 | N/A | N/A |
Currently, INCY's PE ratio is lower than the 3, 5 and 10-year averages.
INCY's PE ratio is lower than its peer stocks LLY and AMGN, but it is greater than NVS's and LGND's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVS Novartis AG | 13.96 | $225.1B |
| LGND Ligand Pharmaceuticals Inc | 19.66 | $1.92B |
| INCY Incyte Corp | 20.6 | $15.41B |
| AMGN Amgen Inc | 47.56 | $179.63B |
| LLY ELI LILLY & Co | 117.98 | $764.72B |
| PFE Pfizer Inc | N/A | $174.36B |
| GERN Geron Corp | N/A | $2.76B |
| ARDX Ardelyx Inc | N/A | $1.31B |
INCY stock has a price to earnings ratio of 20.59 as of Jul 25, 2024.
As an average over the last 3 years, INCY stock has a PE ratio of 28.18.
As an average over the last 5 years, INCY stock has a PE ratio of 32.18.
Over the last ten years, the quarterly PE ratio reached a historic high of 2,711.25 in the Dec 2015 quarter.
INCY's price to earnings ratio is currently 91% below its 10-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jul 25, 2024), Incyte's stock price is $68.57. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $3.33. Therefore, Incyte's P/E ratio for today is 20.59. PE RATIO(20.59) = STOCK PRICE($68.57) / TTM EPS($3.33)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.